Develops monoclonal antibody therapies for patients with autoimmune diseases.
| Title |
|---|
| Senior Director, Regulatory Affairs Strategy Full Time · $270K-$290K · 12+ YOE North America · Remote |
| Director, Medical Science Liaison (MSL) Full Time · $230K-$250K · 3+ YOE United States · Remote |
| Vice President, Drug Safety and Pharmacovigilance (DSPV) Full Time · $400K-$425K · 12+ YOE United States · Remote |
| Executive Director, Commercial Operations Full Time · $290K-$320K · 15+ YOE New York City or United States · Hybrid |
| Director, Marketing Full Time · $210K-$250K · 8+ YOE United States · Hybrid |
| Senior Director, Clinical Pharmacology Full Time · $250K-$305K · 9+ YOE United States · Remote |
| Activities | Biopharmaceutical drug developmentClinical trial managementMonoclonal antibody researchAutoimmune disease therapeuticsPharmaceutical research and development |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Immunovant |
| Employees | 362 |
| Type | Public |
| Parent Company | Roivant Sciences |
| Subsidiaries | IMVT Corporation |
| Tagline | Develops monoclonal antibody therapies for patients with autoimmune diseases. |
| Founded | 2,018 |
| Website | immunovant.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | IMVT |